Skip to content
For laboratory research use only · Not for human consumption
Pioneer Labs

Hormone analogs / Research guide

Cagrilintide.

A little deeper. A clearer picture.

An amylin-inspired peptide engineered with a lipid attachment. Cagrilintide, originally AM833, is a single modified peptide.

For research use onlyView Cagrilintide sizes
Published by Pioneer LabsUpdated Sources & editorial standards

01 / Molecular architecture

A closer look at the chain.

Its design combines an amylin-analog backbone with lipidation. The discovery program examined how modifications influenced stability and receptor activity, including the aggregation challenges associated with native amylin.

Pioneer / Reference notesMolecular features
  • Amylin analog
  • Lipid attachment
  • Calcitonin-family receptors
Structural features shown schematically, not a full sequence or three-dimensional model.

Reference information: [1][2][3]. Actual lot identity must be verified separately.

The receptor includes more than one part.

Amylin-receptor terminology refers to a calcitonin receptor associated with a receptor activity-modifying protein, or RAMP. The RAMP is part of the experimental receptor context. Comparing two activity values without checking the receptor combination can hide a meaningful difference in what was actually tested.

A backbone with an attached lipid.

Cagrilintide combines an amylin-analog backbone with a lipid modification. The backbone and attachment belong to one reference molecule. Lipidation describes that chemical attachment; it is different from adding a separate lipid ingredient to a mixture. The discovery work considered molecular design alongside stability and receptor activity.

Structure and research references: [1][2]

02 / Read the evidence

Research & analytical context.

Receptor profiling examined activity across amylin and calcitonin receptors. Amylin receptors involve a calcitonin receptor paired with a receptor activity-modifying protein (RAMP), so the assay’s receptor composition matters when comparing results.

Read the references: [1][2][3].

The distinction that matters

Cagrilintide is one modified peptide, not a blend. Findings from a combination formulation should not be attributed to cagrilintide alone.

03 / From reference to record

Know the lot, too.

A publication describes its own test material. Your lot’s certificate describes what was tested on that lot. Keep the compound name, batch number and reported methods together when reviewing a result.

Identity & composition

Check sequence or chemical form, terminal modifications, counterion and—where relevant—each blend component.

Analytical results

Read purity, content, sterility and endotoxin results as separate measurements. Only call a test passed when the actual report supports it.

Handling & storage notes

Lyophilized material: Store at −20°C; protect from light and moisture.

Follow the material-specific label and supporting storage documentation. These temperatures do not establish a shelf life.

How to store lyophilized peptides

04 / Reference questions

A few details, explained.

Is cagrilintide a blend?

No. It is one modified peptide with an amylin-related reference design. A study that combines it with another material does not change the identity of either component.

What does AM833 refer to?

AM833 is a development identifier used for cagrilintide in the literature. It can help trace early receptor studies, provided the article’s material definition and assay system are checked alongside the name.

Read alongside the references: [1][2]

05 / Continue reading

Go to the source.